Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00549601 · COMPLETED
Trial details
- NCT number
- NCT00549601
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2009-04-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.